Mutation in EZH2, as shown in our clinical case 1, may also correlate with the presence of a pre-existing MDS/CHIP clone, as they are seen in only a 10% of MDS/MPN cases and never associated with TET2 mutations [2]. This evidence concerns the gene TET2 and myeloproliferative neoplasm.